Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Vaso Corporation is a U.S.-based healthcare services and technology company that provides specialized products and services to hospitals, medical centers, and healthcare providers. The company operates primarily within the healthcare equipment, healthcare information technology, and medical professional services industries. Its core focus is supporting diagnostic imaging, vascular testing, and clinical IT infrastructure within hospital environments.
The company generates revenue through a combination of equipment sales and leasing, healthcare IT solutions, and outsourced professional staffing services. Vaso Corporation is positioned as a niche provider that integrates technology, clinical expertise, and operational support, primarily serving hospitals seeking to outsource non-core diagnostic and IT functions. The company was originally founded in 1987 and has evolved over time from a medical device-focused business into a diversified healthcare services platform through internal development and acquisitions.
Business Operations
Vaso Corporation operates through three primary business segments: Healthcare Information Technology, Healthcare Equipment, and Professional Services. The Healthcare Information Technology segment, conducted primarily through VasoHealthcare IT, Inc., provides IT staffing, infrastructure support, and managed services to hospitals and healthcare systems. This segment has historically been the company’s largest revenue contributor.
The Healthcare Equipment segment, operated through Vaso Diagnostics, Inc. and Vaso Imaging, Inc., focuses on the sale, leasing, and servicing of diagnostic imaging and vascular testing equipment. The Professional Services segment provides clinical staffing and operational services related to diagnostic testing. Operations are primarily domestic within the United States, and the company does not report material international operations. Data inconclusive based on available public sources regarding material joint ventures or international subsidiaries.
Strategic Position & Investments
Vaso Corporation’s strategy centers on expanding recurring revenue streams through long-term service contracts in healthcare IT and diagnostic services. Growth initiatives have emphasized organic expansion within existing hospital clients, particularly in outsourced IT services and clinical support functions. The company has historically pursued targeted acquisitions to strengthen its service offerings, though acquisition activity has been limited in recent years.
Key investments include continued development of healthcare IT staffing capabilities and modernization of diagnostic service offerings. The company does not publicly disclose material investments in emerging technologies such as artificial intelligence or digital health platforms beyond traditional healthcare IT services. Data inconclusive based on available public sources regarding significant recent acquisitions or large-scale strategic investments.
Geographic Footprint
Vaso Corporation is headquartered in New York, United States, and conducts the vast majority of its operations within the United States. Its customer base consists primarily of domestic hospitals and healthcare systems across multiple states, supported through regional service teams and staffing placements.
The company does not report a meaningful operational presence outside North America, and international revenue is not identified as a significant contributor in public disclosures. Any indirect international exposure would be limited to equipment sourcing or vendor relationships. Data inconclusive based on available public sources regarding material international expansion plans.
Leadership & Governance
Vaso Corporation is led by a management team with experience in healthcare services, technology, and finance. The leadership emphasizes operational efficiency, disciplined capital allocation, and long-term relationships with hospital clients. Governance follows standard public company practices as outlined in its filings with the U.S. Securities and Exchange Commission.
Key executives include:
- Jun Ma – Chief Executive Officer and President
- John McCabe – Chief Financial Officer
- Mark Perlman – Chief Operating Officer
- Richard A. Leventhal – Chairman of the Board
The leadership team’s strategic vision focuses on maintaining profitability in niche healthcare services while selectively expanding higher-margin IT and outsourced service offerings.